Figure 1From: A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studiesRepresentative FISH images. (A) Unknown RET rearrangement, (B)RET-KIF5B fusion, (C)RET gene amplifications and (D) low RET gene copy number gain. (E) Loci for RET FISH probes.Back to article page